Review Article Open Access

Multi-Cancer Early Detection (MCED) Tests: A Transformative Approach in Cancer Screening

Abstract

Multi-cancer early detection (MCED) tests represent a rapidly emerging innovation in oncology aimed at identifying multiple cancer types through a single minimally invasive assay, typically based on blood-derived biomarkers such as circulating tumor DNA (ctDNA). Unlike conventional screening methods that target individual cancers, MCED platforms offer the potential to detect malignancies at asymptomatic stages, thereby improving clinical outcomes through earlier intervention. Recent advances in genomics, machine learning, and liquid biopsy technologies have accelerated the development of these tests, although challenges remain regarding sensitivity, specificity, cost-effectiveness, and clinical integration. This short communication highlights the scientific principles, clinical applications, advantages, limitations, and future directions of MCED technologies in modern oncology practice.

Sophie Laurent

To read the full article Download Full Article